| |
No. of cases (n = 54)
|
Adverse Reaction Incidence (%)
|
Adverse Reaction Intensity score (mean ± SD)
|
|---|
| |
Alb
|
DEC
|
Alb + DEC
|
Alb
|
DEC
|
Alb + DEC
|
Alb
|
DEC
|
Alb + DEC
|
|---|
|
≤ 14 years
|
9
|
7
|
8
|
33.3
|
57.1
|
75.0
|
1.0 (± 1.7)
|
5.1 (± 5.1)
|
7.5 (± 5.7)
|
|
> 14 years
|
10
|
10
|
10
|
50.5
|
50.0
|
50.0
|
2.5 (± 3.8)
|
5.9 (± 8.5)
|
6.1 (± 7.4)
|
|
Male
|
10
|
8
|
9
|
50.0
|
62.5
|
55.6
|
2.4 (± 3.8)
|
7.4 (± 8.9)
|
5.8 (± 6.1)
|
|
Female
|
9
|
9
|
9
|
33.3
|
44.4
|
66.7
|
1.1 (± 1.8)
|
4.0 (± 5.0)
|
7.7 (± 7.2)
|
- Alb = albendazole, DEC = diethylcarbamazine citrate, Alb + DEC = albendazole + diethylcarbamazine citrate